Why it matters
The change affects U.S. patients and clinicians considering these specific patches, as well as how their risks are communicated on product labels. The articles do not explain the evidence behind the decision in detail.
DRUGS, DEVICES & RECALLS • UNITED STATES
FDA removes boxed warnings from three menopause estrogen patches
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
BLUF
The FDA has removed boxed warnings about cardiovascular disease, breast cancer and dementia from three estrogen patches used to treat menopause, according to The Guardian. The agency did not convene an advisory committee and gave few details about the scientific basis for the decision, the report says.
HOW THIS BRIEF WAS MADE 2 outlets: 1 national · 1 international. Automated sourcing and summaries by the BLUF engine. Corrections